A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/137 (2006.01) A61K 31/4015 (2006.01) A61K 31/444 (2006.01) A61K 31/522 (2006.01) A61K 31/7076 (2006.01) A61K 38/04 (2006.01) A61K 47/48 (2006.01) A61P 9/00 (2006.01) A61P 9/08 (2006.01) A61P 31/12 (2006.01)
Patent
CA 2461542
The invention relates to the permeability of gap junctions and specifically to agents which modulate same. The invention describes the use of cAMP and/or cAMP phosphodiesterase inhibitors to enhance flow through gap junctions and various synthetic peptides which attenuate flow through gap junctions.
La présente invention concerne la perméabilité de jonctions lacunaires et, spécifiquement, des agents qui modulent ces dernières. Cette invention concerne l'utilisation d'inhibiteurs de monophosphate d'adénosine cyclique (cAMP) et/ou de phosphodiestérase cAMP pour renforcer l'écoulement à travers les jonctions lacunaires et de divers peptides synthétiques qui réduisent l'écoulement à travers les jonctions lacunaires.
Smart & Biggar
University College Cardiff Consultants Limited
University Of Wales College Of Medicine
LandOfFree
Gap junctions and endothelial-derived hyperpolarizing factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gap junctions and endothelial-derived hyperpolarizing factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gap junctions and endothelial-derived hyperpolarizing factor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1347821